Repeat Prostate Biopsy: Rationale, Indications, and Strategies-Reference-Cited by-同舟云学术

Repeat Prostate Biopsy: Rationale, Indications, and Strategies

Published:2015-09 Issue:2 Volume:1 Page:127-136
ISSN:2405-4569
Container-title:European Urology Focus
language:en
Short-container-title:European Urology Focus

Author:

Capitanio Umberto,Pfister David,Emberton Mark

Publisher

Elsevier BV

Subject

Urology

Reference85 articles.

1. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent—update 2013;Heidenreich;Eur Urol,2014

2. American Urological Association (AUA) guideline on prostate cancer detection: process and rationale;Carter;BJU Int,2013

3. NCCN Clinical Practice Guidelines in Oncology. National Comprehensive Cancer Network Web site. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.

4. Prostate cancer: diagnosis and treatment. National Institute for Health and Care Excellence Web site. https://www.nice.org.uk/guidance/cg175. Accessed February 2015.

5. Risk of prostate cancer after detection of isolated high-grade prostatic intraepithelial neoplasia (HGPIN) on extended core needle biopsy: a UK hospital experience;Singh;BMC Urol,2009

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detection Rate of Prostate Cancer in Repeat Biopsy after an Initial Negative Magnetic Resonance Imaging/Ultrasound-Guided Biopsy;Diagnostics;2023-05-17

2. Combination of PI-RADS score and PSAD can improve the diagnostic accuracy of prostate cancer and reduce unnecessary prostate biopsies;Frontiers in Oncology;2022-11-16

3. The value of magnetic resonance imaging-ultrasound fusion targeted biopsies for clinical decision making among patients with previously negative transrectal ultrasound biopsy and persistent prostate-specific antigen elevation;Canadian Urological Association Journal;2022-01-27

4. On the Road to Accurate Protein Biomarkers in Prostate Cancer Diagnosis and Prognosis: Current Status and Future Advances;International Journal of Molecular Sciences;2021-12-17

5. MRI combined with PSA density in detecting clinically significant prostate cancer in patients with PSA serum levels of 4∼10 ng/mL: Biparametric versus multiparametric MRI;Diagnostic and Interventional Imaging;2020-04